Guangzhou Wondfo Biotech Co.,Ltd (SHE: 300482)

Guangzhou Wondfo Biotech Co.,Ltd Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	393.56	840.3	1,163	996.15	1,408	881.05
Short-Term Investments	462.7	623.04	200.26	-	-	-
Trading Asset Securities	1,447	722.45	938.07	572.73	102.6	99.5
Cash & Short-Term Investments	2,303	2,186	2,301	1,569	1,511	980.54
Cash Growth	9.28%	-5.00%	46.65%	3.84%	54.09%	-16.00%
Accounts Receivable	826.87	599.87	540.97	501.78	269.93	421.83
Other Receivables	70.67	51.72	66.6	64.7	68.38	68.4
Receivables	897.55	651.59	607.57	566.48	338.31	490.23
Inventory	412.39	351.4	399.97	386.24	376.66	223.59
Other Current Assets	54.98	44.57	42	63.9	44.41	46.36
Total Current Assets	3,668	3,233	3,350	2,586	2,270	1,741
Property, Plant & Equipment	1,411	1,353	1,189	906.09	676.63	505.86
Long-Term Investments	1,108	709.48	1,284	971.42	1,025	320.01
Goodwill	111.42	111.42	115.37	42.51	48.39	120.13
Other Intangible Assets	190.72	194.52	203.71	208.11	180.19	156.38
Long-Term Deferred Tax Assets	62.61	57.47	53.86	42.77	24.45	23
Long-Term Deferred Charges	87.39	80.03	65.04	69.76	59.48	41.01
Other Long-Term Assets	24.72	32.83	39.41	29.66	21.33	36.89
Total Assets	6,664	5,772	6,301	4,856	4,306	2,944
Accounts Payable	196.38	130.46	320.08	399.99	299.51	156.49
Accrued Expenses	139.27	193.5	229.74	184.01	190.59	130.93
Short-Term Debt	-	4.26	208.42	19.14	101	15.56
Current Portion of Long-Term Debt	-	-	-	12.53	9.07	8.69
Current Portion of Leases	21.7	19.01	16.86	28.24	-	-
Current Income Taxes Payable	40.38	21.84	58.73	4.69	52.69	34.03
Current Unearned Revenue	60.59	72.88	236.31	80.55	97.68	-
Other Current Liabilities	31.35	42.29	70.91	62.4	42.9	97.7
Total Current Liabilities	489.66	484.23	1,141	791.54	793.45	443.4
Long-Term Debt	566.34	552.84	532.49	510.69	501.03	19.72
Long-Term Leases	33.69	27.69	11.19	10.42	0.78	1.77
Long-Term Unearned Revenue	48.88	37.21	23.1	9.4	8.11	10.67
Long-Term Deferred Tax Liabilities	53.35	55.12	55.75	29.7	9.1	7.89
Total Liabilities	1,192	1,157	1,764	1,352	1,312	483.45
Common Stock	471.77	444.52	444.51	444.95	342.57	342.69
Additional Paid-In Capital	1,416	765.52	775.53	787.01	866	863.07
Retained Earnings	3,601	3,433	3,166	2,101	1,637	1,089
Treasury Stock	-118.21	-132.46	-157.3	-139.25	-127.56	-66.62
Comprensive Income & Other	6.63	5.9	115.39	159.18	123.98	-4.35
Total Common Equity	5,377	4,516	4,344	3,353	2,842	2,223
Minority Interest	95.05	98.66	193.8	150.97	151.33	237.22
Shareholders' Equity	5,472	4,615	4,538	3,504	2,994	2,461
Total Liabilities & Equity	6,664	5,772	6,301	4,856	4,306	2,944
Total Debt	621.73	603.8	768.96	581.01	611.89	45.74
Net Cash (Debt)	1,681	1,582	1,532	987.87	899.02	934.8
Net Cash Growth	12.04%	3.27%	55.07%	9.88%	-3.83%	-11.46%
Net Cash Per Share	3.73	3.57	3.47	2.23	2.04	2.12
Filing Date Shares Outstanding	468.22	440.96	441.26	444.95	445.34	445.5
Total Common Shares Outstanding	468.22	440.96	441.26	444.95	445.34	445.5
Working Capital	3,178	2,749	2,209	1,794	1,477	1,297
Book Value Per Share	11.48	10.24	9.84	7.54	6.38	4.99
Tangible Book Value	5,075	4,210	4,025	3,102	2,614	1,947
Tangible Book Value Per Share	10.84	9.55	9.12	6.97	5.87	4.37
Buildings	535.53	530.37	447.3	436.03	202.5	199.18
Machinery	1,054	1,021	940.43	741.37	575.35	431.95
Construction In Progress	359.74	290.84	199.14	16.38	156.18	79.92

Source: S&P Capital IQ. Standard template. Financial Sources.